{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.388","meta":{"versionId":"4","lastUpdated":"2023-04-03T15:22:34.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"CancerLinQ Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2023-04-03"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.388","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1116.388"}],"version":"20171129","name":"NoAdjuvantHormonalTherapyProstate","title":"No Adjuvant Hormonal Therapy Prostate","status":"active","experimental":false,"date":"2017-11-29T01:00:05-05:00","publisher":"CancerLinQ Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","concept":[{"code":"1P","display":"Performance Measure Exclusion Modifier due to Medical Reasons"},{"code":"2P","display":"Performance Measure Exclusion Modifier due to Patient Reasons"},{"code":"4164F","display":"Adjuvant (ie, in combination with external beam radiotherapy to the prostate for prostate cancer) hormonal therapy (gonadotropin-releasing hormone [GnRH] agonist or antagonist) prescribed/administered (PRCA)"}]}]},"expansion":{"identifier":"urn:uuid:81058024-7bd4-47b1-a389-161815da3848","timestamp":"2023-12-10T21:39:24-05:00","total":3,"contains":[{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"1P","display":"Performance Measure Exclusion Modifier due to Medical Reasons"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"2P","display":"Performance Measure Exclusion Modifier due to Patient Reasons"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"4164F","display":"Adjuvant (ie, in combination with external beam radiotherapy to the prostate for prostate cancer) hormonal therapy (gonadotropin-releasing hormone [GnRH] agonist or antagonist) prescribed/administered (PRCA)"}]}}